title: Clinical experience with gadodiamide injection in magnetic resonance imaging of the central nervous system.
authors.affiliation: Nycomed Imaging AS, Oslo, Norway.
authors.forename: E
authors.initials: E
authors.lastname: Andrew
authors.forename: M
authors.initials: M
authors.lastname: Svaland
authors.forename: B
authors.initials: B
authors.lastname: Lundby
authors.forename: F
authors.initials: F
authors.lastname: Hugo
authors.forename: N
authors.initials: N
authors.lastname: LaFrance
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002493:Central Nervous System Diseases / Q000175:diagnosis*; D003287:Contrast Media / Q000009:adverse effects; D004311:Double-Blind Method; D005260:Female; D019786:Gadolinium DTPA; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds / Q000009:adverse effects; D004369:Pentetic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D003287:Contrast Media; D009942:Organometallic Compounds; D004369:Pentetic Acid; C064925:gadodiamide; D019786:Gadolinium DTPA